Monday, September 14, 2026

North Korea Wins Silver After 22 Years, Ryom and Han Shine at Winter Asian Games

North Korea celebrated its first silver medal in 22 years at the Winter Asian Games, showcasing strong performances in figure skating pairs.

How Cortiss’ “REDRED” Captured the Top Spots in 24 Countries: Insights and Trends

Cortis has achieved global success with their hit "REDRED," topping charts in multiple countries and breaking records in K-pop.

THE DEAL Is Done! Canada Just AXED Its Closest Ally To Buy Korean Subs—Is This The End of The US-Canada Defense Pact?

South Korea and Canada discuss enhancing defense cooperation, including a submarine program, to strengthen bilateral relations.

Tag: solid tumors

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Top News

- Our Sponsors Ad -

Follow us